Tricalcium Phosphate
Medically reviewed by Drugs.com. Last updated on Nov 19, 2024.
Excipient (pharmacologically inactive substance)
What is it?
Various calcium phosphates are used as diluents in the pharmaceutical industry. Diluents are added to pharmaceutical tablets or capsules to make the product large enough for swallowing and handling, and more stable.[1]
Some calcium phosphate salts can be anhydrous, meaning the water has been removed from the salt form. Other calcium phosphates are termed dibasic, meaning they have two replaceable hydrogen atoms.
There is no evidence in the available information on calcium phopshate that demonstrates or suggests reasonable grounds to suspect a hazard to the public when they are used at levels that are now current or that might reasonably be expected in the future.[2]
Some examples of medications containing Tricalcium Phosphate
- Carisoprodol 350 mg
- Carisoprodol 250 mg
- Chlor-Trimeton 12 Hour chlorpheniramine maleate 12 mg
- Crestor 40 mg
- Crestor 20 mg
- Crestor 10 mg
- Diclofenac Potassium 50 mg
- Dologesic NF acetaminophen 500 mg / dexbrompheniramine maleate 1 mg
- Gas-X Extra Strength (Chewables) Cherry Creme simethicone 125 mg
- Gas-X Extra Strength (Chewables) Peppermint Creme simethicone 125 mg
- Lamotrigine (Orally Disintegrating) 25 mg
- Lamotrigine (Orally Disintegrating) 100 mg
- Meclizine Hydrochloride 25 mg
- Premarin 0.3 mg
- Premarin 1.25 mg
- Premarin 0.45 mg
- Prempro 0.625 mg / 2.5 mg
- Prempro 0.3 mg / 1.5 mg
- Prenatal Plus Prenatal Vit 27 mg Fe Fumarate 1 mg
- Prenatal Plus Low Iron
References
- Dave RH. Overview of pharmaceutical excipients used in tablets and capsules. Drug Topics (online). Advanstar. 10/24/2008 http://drugtopics.modernmedicine.com/drugtopics/Top+News/Overview-of-pharmaceutical-excipients-used-in-tabl/ArticleStandard/Article/detail/561047. Accessed 03/24/2012
- FDA’s SCOGS database; calcium phosphate dibasic; SCOGS-Report Number: 32; http://www.accessdata.fda.gov/scripts/fcn/fcnDetailNavigation.cfm?rpt=scogsListing&id=58. Accessed March 24, 2012
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.